S100A6 and cancer: With paclitaxel, S100A6 enhanced the sensitivity of cancer cells to paclitaxel-induced colony formation suppression, and suppression of colony formation in S100A6-transfected cells was more obvious than that in control-transfected cells after treatment with paclitaxel.